Pelthos Therapeutics (PTHS) Shares Outstanding (2022 - 2026)
Pelthos Therapeutics' Shares Outstanding came in at 3.54 million for Q2 2026, up 452.6% from 640,518 a year earlier and up 6.9% from the prior quarter.
Powered by 
Analysis
Pelthos Therapeutics (PTHS) Shares Outstanding (2022 - 2026) Analysis & Trends
For FY2025, Pelthos Therapeutics' Shares Outstanding was 1.88 million, up 237.3% from FY2024.
- Shares Outstanding has increased in each of the last three years, with a three-year compound annual growth rate of 250.9% (FY2022 to FY2025).
- Going back by year, Shares Outstanding was 557,447 in FY2024 (+336.7%), 127,654 in FY2023 (+193.2%) and 43,531 in FY2022.
- The Q2 2026 figure represents the highest quarterly Shares Outstanding in data going back to Q4 2022.
- Year-over-year, Shares Outstanding has increased for 11 consecutive quarters, with growth averaging 303.2% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding ran from 10.9% in Q2 2025 to 488.3% in Q3 2024.
- Business Quant data shows PTHS's Shares Outstanding at 3.31 million (Q1 2026), 1.88 million (Q4 2025) and 3.06 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Pelthos Therapeutics | 79.95 Mn | -8.44 Mn | 11.99 Mn | 3.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.54 Mn |
| Mar 31, 2026 | 3.31 Mn |
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | 3.06 Mn |
| Jun 30, 2025 | 640,518.00 |
| Mar 31, 2025 | 612,792.00 |
| Dec 31, 2024 | 557,447.00 |
| Sep 30, 2024 | 579,229.00 |
| Jun 30, 2024 | 577,371.00 |
| Mar 31, 2024 | 469,099.00 |
| Dec 31, 2023 | 127,654.00 |
| Sep 30, 2023 | 98,452.00 |
| Jun 30, 2023 | 100,278.00 |
| Mar 31, 2023 | 111,111.00 |
| Dec 31, 2022 | 43,531.00 |
API Access
Pelthos Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=PTHS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "PTHS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=PTHS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();